子痫前期与胎儿生长受限中的血管生成失衡:可溶性fms样酪氨酸激酶-1结合增强还是胎盘生长因子产生减少?
该研究为前瞻性多中心队列研究的二次分析,纳入407例疑似或确诊子痫前期的孕妇,计算总胎盘生长因子水平。结果显示,尤其在早发型子痫前期合并小于胎龄儿时,胎盘生长因子产生减少是游离胎盘生长因子水平降低的重要原因,降低可溶性fms样酪氨酸激酶-1 unlikely恢复血管生成平衡。
要点
- 早发型子痫前期合并小于胎龄儿时,游离和总胎盘生长因子水平显著降低。
- 子痫前期和小于胎龄儿均可独立增加可溶性fms样酪氨酸激酶-1,二者共存时呈协同作用。
- 作者认为,在早发型子痫前期合并小于胎龄儿时,降低可溶性fms样酪氨酸激酶-1 unlikely恢复血管生成平衡。
核心结论
- 尤其在早发型子痫前期合并小于胎龄儿的妊娠中,胎盘生长因子产生减少是游离胎盘生长因子水平降低的重要原因。
- 在此类情况下,降低可溶性fms样酪氨酸激酶-1 unlikely恢复血管生成平衡。
研究设计与样本
- 前瞻性多中心队列研究的二次分析,纳入407例疑似或确诊子痫前期的妊娠。
- 对照组为妊娠某一时点疑似子痫前期但未发展为子痫前期的孕妇。
- 根据子痫前期早发或晚发(孕龄<34周 vs ≥34周)及分娩时小于胎龄儿的存在进行分层分析。
主要发现
- 早发型子痫前期合并小于胎龄儿组游离和总胎盘生长因子分别为19和44 pg/mL,不合并小于胎龄儿组分别为45和100 pg/mL,均低于无子痫前期组的300和381 pg/mL。
- 早发型子痫前期中,单纯小于胎龄儿未影响游离和总胎盘生长因子,分别为264和352 pg/mL。
- 晚发型子痫前期的观察结果类似,但变化较为温和。
- 小于胎龄儿(孕龄<34周)和子痫前期均独立与可溶性fms样酪氨酸激酶-1升高相关,二者共存时呈协同上调,导致该组可溶性fms样酪氨酸激酶-1/游离胎盘生长因子比值最高。
- 上述现象在早发型和晚发型子痫前期中均出现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess levels of total placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and free PlGF in women with pre-eclampsia (PE) with or without a small-for-gestational-age (SGA) neonate in order to establish whether low free PlGF levels associated with PE and SGA are due to enhanced sFlt-1 binding or decreased PlGF production. METHODS: This was a secondary analysis of a prospective multicenter cohort study involving 407 pregnancies with suspected or confirmed PE, in which total PlGF levels were calculated from measured sFlt-1 and free PlGF levels. The control group included women who were suspected to have PE at a certain point in pregnancy but did not develop PE. The analysis was stratified according to whether PE was early- or late-onset (gestational age < 34 weeks vs ≥ 34 weeks) and according to the presence of SGA at birth, which was used as a proxy of fetal growth restriction in the absence of Doppler ultrasound and biometric data. RESULTS: In early-onset PE, both women with and those without SGA had lower free (19 and 45 pg/mL) and total (44 and 100 pg/mL) PlGF levels compared with women without PE (free and total PlGF, 300 and 381 pg/mL, respectively). SGA alone did not affect free and total PlGF in this condition (free and total PlGF, 264 and 352 pg/mL, respectively). Observations in women with late-onset PE were similar, although the changes were more modest. Both SGA (gestational age < 34 weeks) and PE were individually associated with increased sFlt-1 and, in women with both PE and SGA, the upregulation of sFlt-1 occurred in a synergistic manner, thus resulting in the highest sFlt-1/free PlGF ratio in this group. This occurred in both early- and late-onset PE. CONCLUSIONS: Particularly in pregnancies with early-onset PE and SGA, diminished PlGF production is an important cause of low free PlGF levels. Under such conditions, sFlt-1 lowering is unlikely to restore the angiogenic balance. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kluivers ACM, Biesbroek A, Visser W, et al. Angiogenic imbalance in pre-eclampsia and fetal growth restriction: enhanced soluble fms-like tyrosine kinase-1 binding or diminished production of placental growth factor? Ultrasound Obstet Gynecol. 2023. PMID: 36191149. doi:10.1002/uog.26088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。